ArticleSmall methods2025
Self-Disassembling Macroporous Metal-Organic Framework-Based Micromotors with Magnetically Controlled Motion for Sequential Drug Release.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metal-Organic Framework Nanozymes: From Rational Design and Synthesis to Biomedical Applications.Nano-micro letters · 2026Review
- Self-Disassembling Macroporous Metal-Organic Framework-Based Micromotors with Magnetically Controlled Motion for Sequential Drug Release.Small methods · 2025Article
- Folate-Modified Smart Responsive Nanosystems for Enhancing Anti-Tumor Therapy Through Calcium Overload and Chemotherapy.International journal of nanomedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Herein, the synthesis of macroporous zeolitic imidazole framework (ZIF)-based magnetic micromotors (MMs) for the dual encapsulation of 5-fluorouracil (5-FU) and doxorubicin (DOX), with pH-triggered release is described. The MMs are synthesized in methanolic solutions, using superparamagnetic iron oxide nanoparticles (Fe₃O₄) as seeding agents and magnetic engines. The macroporous structure facilitates the loading of high doses of 5-FU, while DOX is docked on the surface of the MMs. This results in release rates of 72.8 µg mg MMs⁻¹ of 5-FU and 3 µg mg MMs⁻¹ of DOX. The magnetic motion of the MMs enables targeted delivery to predefined locations, allowing interaction with cancer cells in the culture medium. Under acidic conditions, DOX becomes protonated and is released from the surface of the micromotors, demonstrating rapid-release kinetics. Simultaneously, the ZIF-8 structure degrades under these conditions, enabling the sustained release of 5-FU for continuous treatment. This dual-delivery, pH-induced mechanism is demonstrated in vitro using Caco-2 cells as a relevant biological model, revealing a decrease in viability and diffusion of the drugs released into the cells. This is the first magnetic metal-organic framework (MOF)-based MM that is pH-sensitive and capable of sequentially releasing two drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.